IL6 and acute kidney injury: In a cisplatin-induced acute kidney injury model, treatment with PLA2 attenuated tissue damage by reducing serum creatinine, blood urea nitrogen, production of pro-inflammatory cytokines, such as IL-6 and TNF-α, and macrophage infiltration [59].